본문 바로가기
KERD
논문KCI 등재

장미색비강진에 대한 동서의학적 고찰

The Study on the Pityriasis Rosea in Oriental-Western Medicine

이규영
대한한방안이비인후피부과학회 (The Korean Medicine Opthalmology&Otolaryngology&Dermatology Society)|2022.11|한방안이비인후피부과학회지 (The Journal of Korean Medicine Ophthalmology&Otorhinolaryngology&Dermatology)|제35권 제4호|pp. 106-122

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

Korean medicineReviewPityriasis rosea
주제분류한의학

초록

Objectives : In this study, we aimed to analyze the latest knowledge of pityriasis rosea(PR) through oriental-western medical review on PR. Methods : We searched Pubmed, CNKI, and OASIS to select papers related to the cause, mechanism, diagnosis, classification, treatment, and herbal treatment of PR. Results : The results are as follows. 1. Although the exact cause of PR is not known, it has recently been found that reactivation of latent human herpesvirus-6 and human herpesvirus-7 infection is a possible etiology. Most patients require emollients, antihistamines, topical steroids, and macrolides. Acyclovir, and narrow-band UVB therapy are also used. 2. The cause and mechanism of PR in Chinese and Korean medicine can be mainly summarized as wind-heat, blood heat, and blood deficiency and wind-dryness. Most of the herbal medicine used have the effects of clearing heat, cooling the blood, detoxifying, dispelling wind, relieving itching, nourishing blood, and moistening dryness. Conclusions : In Chinese and Korean medicine, it is necessary to organize the representative prescriptions according to pattern identification, and it is also necessary to study the atypical types of PR and its treatment methods. It is thought that research on oriental and western combination therapy should be continuously conducted, and efforts to develop Korean medicine formulations are needed to revitalize clinical research in Korea.

Abstract

Objectives : In this study, we aimed to analyze the latest knowledge of pityriasis rosea(PR) through oriental-western medical review on PR. Methods : We searched Pubmed, CNKI, and OASIS to select papers related to the cause, mechanism, diagnosis, classification, treatment, and herbal treatment of PR. Results : The results are as follows. 1. Although the exact cause of PR is not known, it has recently been found that reactivation of latent human herpesvirus-6 and human herpesvirus-7 infection is a possible etiology. Most patients require emollients, antihistamines, topical steroids, and macrolides. Acyclovir, and narrow-band UVB therapy are also used. 2. The cause and mechanism of PR in Chinese and Korean medicine can be mainly summarized as wind-heat, blood heat, and blood deficiency and wind-dryness. Most of the herbal medicine used have the effects of clearing heat, cooling the blood, detoxifying, dispelling wind, relieving itching, nourishing blood, and moistening dryness. Conclusions : In Chinese and Korean medicine, it is necessary to organize the representative prescriptions according to pattern identification, and it is also necessary to study the atypical types of PR and its treatment methods. It is thought that research on oriental and western combination therapy should be continuously conducted, and efforts to develop Korean medicine formulations are needed to revitalize clinical research in Korea.

참고문헌 (52)

  1. The society of Korean medicine Ophthalmology, Otolaryngology & Dermatology, "Text of Traditional Korean Dermatology & Surgery", pp.97~100 (2022), Globooks
  2. 곽재영, "은교산으로 호전된 소아 장미색 비강진 3례", 한방안이비인후피부과학회지, 30(2), pp.155~164 (2017), 대한한방안이비인후피부과학회[DOI]
  3. 정민영, "장미색 비강진 한방 치험 1례", 한방안이비인후피부과학회지, 20(3), pp.268~275 (2007), 대한한방안이비인후피부과학회
  4. 진한솔, "장미색 비강진의 한방 탕약 치료에 대한 연구 : 체계적 문헌 고찰", 한방안이비인후피부과학회지, 34(4), pp.117~133 (2021), 대한한방안이비인후피부과학회
  5. Veraldi S, "Pityriasis rosea and COVID-19", J Med Virol, 93(7), pp.4068~ (2021)
  6. Drago F, "Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19", J Med Virol, 93(4), pp.1850~ (2021)
  7. Dursun R, "The clinics of HHV-6infection in COVID-19 pandemic : pityriasis rosea and Kawasaki disease", Dermatol Ther, 33(4), pp.e13730~ (2020)
  8. Ciccarese G, "SARS-CoV-2as possible inducer of viral reactivations", Dermatol Ther, 33(6), pp.e13878~ (2020)
  9. Brambilla L, "Herpes Zoster following COVID-19 : a report of three cases", Eur J Dermatol, 30(6), pp.754~756 (2020)
  10. Marcantonio-Santa Cruz OY, "Pityriasis rosea developing after COVID-19 vaccination", J Eur Acad Dermatol Venereol, 35(11), pp.721~722 (2021)
  11. Drago F, "Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions : a review of the literature", J Eur Acad Dermatol Venereol, 30, pp.544~ (2016)
  12. Gay JT, "Herald Patch", pp.1~6 (2022), Treasure Island (FL):StatPearls Publishing
  13. Engelmann I, "Relapsing Pityriasis Rosea With HHV-7 Reactivation in an 11-Year-Old Girl", Pediatrics, 141(5), pp.e20173179~ (2018)
  14. Alame MM, "Pityriasis rosea-like eruption associated with ondansetron use in pregnancy", Br J Clin Pharmacol, 84(5), pp.1077~1080 (2018)
  15. Litchman G, "Pityriasis Rosea", pp.1~7 (2022), Treasure Island (FL):StatPearls Publishing
  16. Gangemi S, "Increased serum levels of interleukin-22 in patients affected by pityriasis rosea", J Eur Acad Dermatol Venereol, 23, pp.858~ (2009)
  17. Gangemi S, "The CX3C-chemokine frac-talkine(CX3CL1)is detectable in serum of patients affected by active pityriasis rosea", J Eur Acad Dermatol Venereol, 20, pp.1366~ (2006)
  18. Mostafa Abou El-Ela, "Higher Expression of Toll-like Receptors 3, 7, 8, and 9 in Pityriasis Rosea", Journal of Pathology and Translational Medicine, 51(2), pp.148~151 (2017), 대한병리학회[DOI]
  19. Trinchieri G, "Cooperation of Toll-like receptor signals in innate immune defence", Nat Rev Immunol, 7, pp.179~190 (2007)
  20. Wagner H, "The immunobiology of the TLR9subfamily", Trends Immunol, 25, pp.381~386 (2004)
  21. Trayes KP, "Annular Lesions : Diagnosis and Treatment", Am Fam Physician, 98(5), pp.283~291 (2018)
  22. Milton Rodriguez-Zuniga, "Effectiveness of acyclovir in the treatment of pityriasis rosea. A systematic review and meta-analysis", Anais Brasileiros de Dermatologia, 93(5), pp.686~695 (2018), FapUNIFESP (SciELO)[DOI]
  23. Sonthalia S, "Double-blind randomized placebo-controlled trial to evaluate the efficacy and safety of short-course low-dose oral prednisolone in pityriasis rosea", J Dermatolog Treat, 29(6), pp.617~622 (2018)
  24. Chuh AA, "Diagnostic criteria for pityriasis rosea : A prospective case control study for assessment of validity", J Eur Acad Dermatol Venereol, 17, pp.101~103 (2003)
  25. Zawar V, "Applicability of proposed diagnostic criteria of pityriasis rosea : Results of a prospective case-control study in India", Indian J Dermatol, 58, pp.439~442 (2013)
  26. Mahajan K, "Pityriasis Rosea : An Update on Etiopathogenesis and Management of Difficult Aspects", Indian J Dermatol, 61(4), pp.375~384 (2016)
  27. Drago F, "Pityriasis rosea : an update with a critical appraisal of its possible herpesviral etiology", J Am Acad Dermatol, 61, pp.303~318 (2009)
  28. Drago F, "Use of high-dose acyclovir in pityriasis rosea", J Am Acad Dermatol, 54, pp.82~85 (2006)
  29. Drago F, "Relapsing pityriasis rosea", Dermatology, 229, pp.316~318 (2014)
  30. Drago F, "Persistent pityriasis rosea : an unusual form of pityriasis rosea with persistent active HHV-6 and HHV-7infection", Dermatology, 230, pp.23~26 (2015)
  31. Vidimos AT, "Tongue and cheek : oral lesions in pityriasis rosea", Cutis, 50, pp.276~280 (1992)
  32. Bjornberg A, "Pityriasis rosea. A statistical, clinical, and laboratory investigation of 826 patients and matched healthy controls", Acta Derm Venereol Suppl(Stockh), 42, pp.1~68 (1962)[DOI]
  33. Drago F, "Pityriasis rosea in children : clinical features and laboratory investigations", Dermatology, 231, pp.9~14 (2015)
  34. Hall CB, "Human herpesvirus-6 infection in children. A prospective study of complications and reactivation", N Engl J Med, 331, pp.432~438 (1994)
  35. Corson EF, "Coincidence with pityriasis rosea with pregnancy", AMA Arch Derm Syphilol, 62, pp.562~564 (1950)
  36. Drago F, "Pregnancy outcome in patients with pityriasis rosea", J Am Acad Dermatol, 58, pp.S78~83 (2008)
  37. Drago F, "Evidence of human herpesvirus-6 and 7 reactivation in miscarrying women with pityriasis rosea", J Am Acad Dermatol, 71, pp.198~ (2014)
  38. Drago F, "Pityriasis rosea and pityriasis rosea-like eruption : can they be distinguished?", J Dermatol, 41, pp.864~ (2014)
  39. Drago F, "Pityriasis rosea and pityriasis rosea-like eruptions", J Am Acad Dermatol, 70, pp.196~ (2014)
  40. Drago F, "Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions : a review of the literature", J Eur Acad Dermatol Venereol, 30, pp.544~ (2016)
  41. Krishnamurthy K, "To treat or not to treat? Management of guttate psoriasis and pityriasis rosea in patients with evidence of group A Streptococcal infection", J Drugs Dermatol, 9(3), pp.241~250 (2010)
  42. Jairath V, "Narrowband UVB phototherapy in pityriasis rosea", Indian Dermatol Online J, 6, pp.326~329 (2015)
  43. Yun GJ, "Clinical application of Yinxieling ointment and pricking cupping bloodletting in treating pityriasis rosea", China’s Naturopathy, 9, pp.39~41 (2018)
  44. Zhang JY, "Clinical Observation on Treatment of Blood Heat and Exuberant Wind Type Pityriasis Rosea with Liangjie Xiaozhen Decoction", Master, pp.2019
  45. Zheng ZG, "Clinical Observation on Yinqiao Powder Combined with Western Medicine in the Treatment of Pityriasis Rosea", Chinese Medicine Modern Distance Education of China, 4, pp.250~252 (2020)
  46. Zhao WC, "Clinical study on the treatment of pityriasis rosea with wind-heat and skin retaining method by soothing wind and heat", Master, pp.2021
  47. Jing C, "The clinical observation of Tuizhen Xiaoban Decoction in the treatment of wind-heat and blood dry type pityriasis rosea", Master, pp.2019
  48. Geo JS, "Clinical observation of 24 cases of pityriasis rosea with blood deficiency and wind-dryness type treated with Dangguiyinzi modified and subtracted combined with auricular point pressure method", The Journal of Medical Theory and Practice, 3, pp.443~445 (2022)
  49. Liu G, "Clinical Observation on 12 Cases of Refractory Pityriasis Rosea Treated by Integrated Traditional Chinese and Western Medicine", China’s Naturopathy, 3, pp.60~61 (2019)
  50. Chen JH, "Clinical study on the treatment of wind-heat and blood-dry type pityriasis rosea with integrated traditional Chinese and western medicine", Chinese Manipulation ＆Rehabilitation Medicine, 16, pp.34~36 (2019)
  51. Wang YQ, "Research progress on diagnosis and treatment of pityriasis rosea by integrated traditional Chinese and western medicine", Shandong Journal of Traditional Chinese Medicine, 4, pp.384~389 (2019)
  52. "The Minjok Medicine News" (2012)[URL]

관련 논문AI추천

장미색 비강진의 한방 탕약 치료에 대한 연구 : 체계적 문헌 고찰고우신, 윤화정, 임희영, 진한솔대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2021 · 제34권 제4호은교산으로 호전된 소아 장미색 비강진 3례곽재영, 김민희, 신상호, 안진향, 윤영희, 최인화대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2017 · 제30권 제2호장미색 비강진 한방 치험 1례김대수, 김민정, 김종환, 박수연, 박용호, 정민영, 최정화대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2007 · 제20권 제3호성인형 모공성 홍색 비강진에 대한 한방치료 증례 보고 1례강세영, 전상우대한한방내과학회 · 대한한방내과학회지2020 · 제41권 제5호중국 논문에 나타난 건선의 변증 분석 및 변증체계에 대한 고찰김규석, 조은채대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2020 · 제33권 제2호건선의 변증유형과 한약치료에 대한 증례 분석백정한, 조연수대한한방소아과학회 · 대한한방소아과학회지2017 · 제31권 제1호

이 간행물의 다른 논문 (15건)

안면마비 증상을 호소하는 환자의 양방 치료 후한방 치료 경험에 대한 질적 연구이지현, 김규석, 김종한, 윤석영pp. 1-30대전한방병원 한방안이비인후피부과로 내원한 돌발성 난청 환자 특성 분석 - 2013년 1월부터 2021년 12월까지 -백종찬, 정현아, 안재현, 황미리, 최윤영, 변정아pp. 31-46勞瘵란 무엇일까?송창은, 장정환, 서형식pp. 47-62풋사과 추출물의 피부 보습 효과구세광, 최범락, 제갈경환, 박혜림, 김재광, 김종대, 이재경pp. 63-74네트워크 약리학을 이용한 소양증을 동반한 피부 염증에 대한 枳實의 잠재적 치료기전 탐색김병현, 김규석, 서광일, 김윤범, 김준동, 남혜정pp. 75-94
원문 보기